Autoimmune Diseases  >>  oral insulin (ORMD-0801)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oral insulin (ORMD-0801) / Oramed
NCT00867594: Effectiveness of Oral Insulin in Unstable Type 1 Diabetes Patients

Checkmark
Dec 2013 - Dec 2013: 
Checkmark
Apr 2013 - Apr 2013: 
Completed
2
12
RoW
ORMD 0801
Hadassah Medical Organization, Oramed Pharmaceutical Inc.
Brittle Type I Diabetes Mellitus
08/08
08/08
NCT02094534: A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics

Completed
2
25
US
ORMD-0801 Capsules, Oral Insulin, Placebo, Fish Oil
Oramed, Ltd., Integrium
Diabetes Mellitus Type 1
08/14
10/14

Download Options